More on Clorox's (CLX) FQ1: Growth in sales paced by higher prices as volume slipped 1%. Gross...


More on Clorox's (CLX) FQ1: Growth in sales paced by higher prices as volume slipped 1%. Gross margin up 110 bps to 42.9% with cost savings initiatives clicking. Household segment profits drove 19% higher despite lower sales numbers. The company expects FY13 EPS in the range of $4.20-$4.35. Shares +0.1% premarket. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs